Zhejiang Tailin Bioengineering Co Ltd (300813) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has a cash flow conversion efficiency ratio of 0.015x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.74 Million ≈ $1.72 Million USD) by net assets (CN¥790.14 Million ≈ $115.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Tailin Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Tailin Bioengineering Co Ltd total liabilities for a breakdown of total debt and financial obligations.
Zhejiang Tailin Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mercuries & Associates Holding Ltd
TW:2905
|
0.011x |
|
Pondy Oxides & Chemicals Limited
NSE:POCL
|
0.171x |
|
Lux Industries Limited
NSE:LUXIND
|
-0.130x |
|
Banestes S.A - Banco do Estado do Espírito Santo
SA:BEES3
|
-1.747x |
|
Xinjiang Torch Gas Co Ltd
SHG:603080
|
0.083x |
|
Unusual Machines, Inc.
NYSE MKT:UMAC
|
-0.071x |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
0.013x |
|
Panin Financial Tbk
JK:PNLF
|
0.014x |
Annual Cash Flow Conversion Efficiency for Zhejiang Tailin Bioengineering Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Zhejiang Tailin Bioengineering Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥820.73 Million ≈ $120.10 Million |
CN¥24.66 Million ≈ $3.61 Million |
0.030x | +911.17% |
| 2023-12-31 | CN¥650.24 Million ≈ $95.15 Million |
CN¥1.93 Million ≈ $282.70K |
0.003x | -97.85% |
| 2022-12-31 | CN¥647.45 Million ≈ $94.74 Million |
CN¥89.39 Million ≈ $13.08 Million |
0.138x | +90.94% |
| 2021-12-31 | CN¥497.38 Million ≈ $72.78 Million |
CN¥35.96 Million ≈ $5.26 Million |
0.072x | -69.78% |
| 2020-12-31 | CN¥444.24 Million ≈ $65.01 Million |
CN¥106.28 Million ≈ $15.55 Million |
0.239x | +88.75% |
| 2019-12-31 | CN¥229.11 Million ≈ $33.53 Million |
CN¥29.04 Million ≈ $4.25 Million |
0.127x | -33.89% |
| 2018-12-31 | CN¥194.70 Million ≈ $28.49 Million |
CN¥37.33 Million ≈ $5.46 Million |
0.192x | +21.87% |
| 2017-12-31 | CN¥146.48 Million ≈ $21.44 Million |
CN¥23.04 Million ≈ $3.37 Million |
0.157x | -42.03% |
| 2016-12-31 | CN¥116.31 Million ≈ $17.02 Million |
CN¥31.56 Million ≈ $4.62 Million |
0.271x | +7.74% |
| 2015-12-31 | CN¥97.42 Million ≈ $14.26 Million |
CN¥24.54 Million ≈ $3.59 Million |
0.252x | -20.82% |
| 2014-12-31 | CN¥55.04 Million ≈ $8.05 Million |
CN¥17.51 Million ≈ $2.56 Million |
0.318x | +79.38% |
| 2013-12-31 | CN¥64.92 Million ≈ $9.50 Million |
CN¥11.51 Million ≈ $1.68 Million |
0.177x | -- |
About Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly activ… Read more